EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pharmacokinetic and pharmacodynamic characterization of gepotidacin against Escherichia coli and Klebsiella pneumoniae in a neutropenic mouse thigh infection model

Christine M Singley, Abhinav Kurumaddali, Jennifer L Hoover iD

Antimicrobial Agents and Chemotherapy · 2026

DOI: 10.1128/aac.01176-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2026. Verfasst von Christine M Singley und 2 weiteren Autor:innen. Beteiligte Einrichtung: GSK, Collegeville, Pennsylvania, USA. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, Escherichia coli, Anti-Bacterial Agents, Klebsiella Infections. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gepotidacin is a novel first-in-class triazaacenaphthylene antibiotic developed for the treatment of uncomplicated gonorrhea and uncomplicated urinary tract infections (uUTIs). To support uUTI, in vivo pharmacokinetics (PK)/pharmacodynamics (PD) studies have been conducted in the murine neutropenic thigh infection model evaluating gepotidacin against 17 isolates of Escherichia coli and 7 isolates of Klebsiella pneumoniae having MICs of 0.25 to 16 µg/mL. Exposure data were fit using a population PK model, and efficacy data were fit with an inhibitory effect sigmoid Imax model using free-drug area under the concentration-time curve (fAUC)/MIC as the primary index. The ratios associated with response were determined for each isolate, and the median fAUC/MIC (excluding strains with

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Klebsiella pneumoniaeEscherichia coliAnti-Bacterial AgentsKlebsiella InfectionsAcenaphthenesEscherichia coli InfectionsHeterocyclic Compounds, 3-RingNeutropeniaAnimalsMiceMicrobial Sensitivity TestsThighFemaleDisease Models, AnimalUrinary Tract Infections

Stichwörter der Autor:innen

PK/PDUTIgepotidacinin vivo

Substanzen

Anti-Bacterial AgentsgepotidacinAcenaphthenesHeterocyclic Compounds, 3-Ring

Autor:innen und Institutionen

  • GSK, Collegeville, Pennsylvania, USA.

ORCID-Profile: Jennifer L Hoover

Zitieren

APA

Singley, C. M., Kurumaddali, A., & Hoover, J. L. (2026). Pharmacokinetic and pharmacodynamic characterization of gepotidacin against Escherichia coli and Klebsiella pneumoniae in a neutropenic mouse thigh infection model. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01176-25

Vancouver

Singley CM, Kurumaddali A, Hoover JL. Pharmacokinetic and pharmacodynamic characterization of gepotidacin against Escherichia coli and Klebsiella pneumoniae in a neutropenic mouse thigh infection model. Antimicrobial Agents and Chemotherapy. 2026. doi:10.1128/aac.01176-25

BibTeX
@article{Singley2026,
  author = {Singley, Christine M and Kurumaddali, Abhinav and Hoover, Jennifer L},
  title = {Pharmacokinetic and pharmacodynamic characterization of gepotidacin against Escherichia coli and Klebsiella pneumoniae in a neutropenic mouse thigh infection model},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2026},
  doi = {10.1128/aac.01176-25}
}
Kostenlos starten →